[go: up one dir, main page]

AU5626998A - Conjugate vaccine against group B Streptococcus - Google Patents

Conjugate vaccine against group B Streptococcus

Info

Publication number
AU5626998A
AU5626998A AU56269/98A AU5626998A AU5626998A AU 5626998 A AU5626998 A AU 5626998A AU 56269/98 A AU56269/98 A AU 56269/98A AU 5626998 A AU5626998 A AU 5626998A AU 5626998 A AU5626998 A AU 5626998A
Authority
AU
Australia
Prior art keywords
streptococcus
vaccine against
conjugate vaccine
against group
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56269/98A
Other versions
AU722078B2 (en
Inventor
Frederick M. Ausubel
Dennis L Kasper
Lawrence C Madoff
James L Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
General Hospital Corp
Original Assignee
Brigham and Womens Hospital Inc
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU56654/94A external-priority patent/AU689452B2/en
Application filed by Brigham and Womens Hospital Inc, General Hospital Corp filed Critical Brigham and Womens Hospital Inc
Priority to AU56269/98A priority Critical patent/AU722078B2/en
Publication of AU5626998A publication Critical patent/AU5626998A/en
Application granted granted Critical
Publication of AU722078B2 publication Critical patent/AU722078B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU56269/98A 1992-11-02 1998-02-23 Conjugate vaccine against group B Streptococcus Ceased AU722078B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU56269/98A AU722078B2 (en) 1992-11-02 1998-02-23 Conjugate vaccine against group B Streptococcus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US968866 1992-11-02
AU56654/94A AU689452B2 (en) 1992-11-02 1993-11-02 Conjugate vaccine against group B streptococcus
AU56269/98A AU722078B2 (en) 1992-11-02 1998-02-23 Conjugate vaccine against group B Streptococcus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU56654/94A Division AU689452B2 (en) 1992-11-02 1993-11-02 Conjugate vaccine against group B streptococcus

Publications (2)

Publication Number Publication Date
AU5626998A true AU5626998A (en) 1998-05-07
AU722078B2 AU722078B2 (en) 2000-07-20

Family

ID=3742217

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56269/98A Ceased AU722078B2 (en) 1992-11-02 1998-02-23 Conjugate vaccine against group B Streptococcus

Country Status (1)

Country Link
AU (1) AU722078B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2754000B2 (en) * 1986-04-16 1998-05-20 ザ ブリガム アンド ウィメンズ ホスピタル,インコーポレイテッド Bacterial antigen, antibody, vaccine and method for producing the same
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus

Also Published As

Publication number Publication date
AU722078B2 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
AU3892395A (en) Oligomers having heteroatom-linked conjugate groups
AU6858391A (en) Bundle tie
CZ197595A3 (en) Vaccine preparations
AU6018194A (en) Easy intubator
HUT70981A (en) Conjugate vaccine against group b streptococcus
ZA937034B (en) Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
AU6888794A (en) Shampoo system
AU2623795A (en) Immunogenic pharmaceuticals
AU1589392A (en) Regenerative heat-exchanger
AU3154395A (en) Contraceptive vaccine
AU5695694A (en) Easy open end
AU2769595A (en) Contraceptive vaccine
AU3263493A (en) Tonometer
AU6820796A (en) Antigenic preparations
AU4450696A (en) Enhanced immunogenic vaccine
AU3552797A (en) Vaccine preparations
AU1538895A (en) Anti-allergic vaccine
AU3461793A (en) Amphotericin B derivatives
AU5959494A (en) Vaccines against sterols
AU4970193A (en) IPNV vaccine
AU5626998A (en) Conjugate vaccine against group B Streptococcus
AU4762993A (en) Keratometer
AU3460693A (en) Amphotericin B derivative
AU6409894A (en) Recognin vaccines
AU1851392A (en) Ccv vaccine

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)